Literature DB >> 12821259

Left ventricular structural and functional characteristics in Cushing's syndrome.

Maria Lorenza Muiesan1, Mario Lupia, Massimo Salvetti, Consuelo Grigoletto, Nicoletta Sonino, Marco Boscaro, Enrico Agabiti Rosei, Franco Mantero, Francesco Fallo.   

Abstract

OBJECTIVES: This study was designed to evaluate left ventricular (LV) anatomy and function in patients with Cushing's syndrome.
BACKGROUND: A high prevalence of LV hypertrophy and concentric remodeling has been reported in Cushing's syndrome, although no data have been reported on LV systolic and diastolic function.
METHODS: Forty-two consecutive patients with Cushing's syndrome and 42 control subjects, matched for age, gender, and blood pressure, were studied. Left ventricular mass index (LVMI) and relative wall thickness (RWT) were measured by echocardiography, endocardial and midwall fractional shortening (FS) were assessed, and diastolic filling was measured by Doppler transmitral flow.
RESULTS: The RWT was significantly greater in Cushing patients than in controls. Left ventricular hypertrophy and concentric remodeling were observed in 10 and 26 patients with Cushing's syndrome, respectively. In Cushing patients, midwall FS was significantly reduced compared with controls (16.2 +/- 3% vs. 21 +/- 4.5%, p = 0.01). The ratio of transmitral E and A flow velocities was reduced and E deceleration time was prolonged in Cushing patients compared with controls (p = 0.03 and p < 0.001, respectively).
CONCLUSIONS: In patients with Cushing's syndrome, cardiac structural changes are associated with reduced midwall systolic performance and with diastolic dysfunction that may contribute to the high risk of cardiovascular events observed in these patients.

Entities:  

Mesh:

Year:  2003        PMID: 12821259     DOI: 10.1016/s0735-1097(03)00493-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  48 in total

1.  Reversible cushing dilated cardiomyopathy mimicking peripartum cardiomyopathy with successful subsequent pregnancy.

Authors:  Rashed Al Banna; Aysha Husain; Jalila Al Aali; Khalid Ebrahim; Abdulaziz Mohammed
Journal:  BMJ Case Rep       Date:  2011-11-08

Review 2.  Cardiovascular risk in Cushing's syndrome.

Authors:  Giorgio Arnaldi; Tatiana Mancini; Barbara Polenta; Marco Boscaro
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

3.  Echocardiographic alterations in patients with non-functioning adrenal incidentaloma.

Authors:  F Ermetici; C Dall'Asta; A E Malavazos; C Coman; L Morricone; V Montericcio; B Ambrosi
Journal:  J Endocrinol Invest       Date:  2008-06       Impact factor: 4.256

4.  Cardiac hypertrophy in Cushing's syndrome: if not hypertension then what?

Authors:  D A Vassiliadi; S Tsagarakis
Journal:  Endocrine       Date:  2017-02-17       Impact factor: 3.633

Review 5.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

6.  Impact of vitamin D3 on cardiovascular responses to glucocorticoid excess.

Authors:  Mona A Ahmed
Journal:  J Physiol Biochem       Date:  2012-09-19       Impact factor: 4.158

7.  Left ventricular geometry and 24-h blood pressure profile in Cushing's syndrome.

Authors:  Eleonora Avenatti; Andrea Rebellato; Andrea Iannaccone; Marialberta Battocchio; Francesca Dassie; Franco Veglio; Alberto Milan; Francesco Fallo
Journal:  Endocrine       Date:  2016-05-14       Impact factor: 3.633

8.  Blockade of glucocorticoid receptors with RU486 attenuates cardiac damage and adipose tissue inflammation in a rat model of metabolic syndrome.

Authors:  Yuuri Takeshita; Shogo Watanabe; Takuya Hattori; Kai Nagasawa; Natsumi Matsuura; Keiji Takahashi; Toyoaki Murohara; Kohzo Nagata
Journal:  Hypertens Res       Date:  2015-07-09       Impact factor: 3.872

9.  Dual role for glucocorticoids in cardiomyocyte hypertrophy and apoptosis.

Authors:  Rongqin Ren; Robert H Oakley; Diana Cruz-Topete; John A Cidlowski
Journal:  Endocrinology       Date:  2012-09-18       Impact factor: 4.736

10.  Blood Pressure and Left Ventricular Characteristics in Young Patients with Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.

Authors:  Graziamaria Ubertini; Carla Bizzarri; Armando Grossi; Fabrizio Gimigliano; Lucilla Ravà; Danilo Fintini; Marco Cappa
Journal:  Int J Pediatr Endocrinol       Date:  2010-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.